Document Classification

Section Type: RESULTS

Text: In study 1 AAS administration led to decreases in serum concentrations of HDL-C (from 1. 08 (0. 30) to 0. 43 (0. 22) mmol/l), HDL2-C (from 0. 21 (0. 18) to 0. 05 (0. 03) mmol/l), HDL3-C (from 0. 87 (0. 24) to 0. 40 (0. 20) mmol/l, and Apo-A1 (from 1. 41 (0. 27) to 0. 71 (0. 34) g/l), whereas Apo-B increased from 0. 96 (0. 13) to 1. 32 (0. 28) g/l.